Alignment Healthcare Q3 2026: Revenue Beats, Medical Costs Bite

As seen on the 24/7 Wall St. homepage on October 29, 2026.

ALHC Alignment Healthcare
Q3 2026
EPS
-$0.04
est $0.04 -194.1%
Revenue
$1.36B
est $1.31B +3.4%

Medical costs are eating the growth story: the medical benefits ratio climbed to 89.5%, flipping Alignment Healthcare to a quarterly loss even as revenue grew and topped expectations. Management now guides to an adjusted EBITDA loss of as much as $28 million in the fourth quarter, with no credit for the fixes already underway.

Continue ReadingShow less

Alignment Healthcare's third-quarter revenue beat expectations, but the medical benefits ratio climbed to 89.5% on elevated appeals and disputes, catastrophic cases, and skilled nursing expenses, offsetting all of that top-line strength.

Those cost pressures flipped the company to a GAAP net loss of $8.05 million from net income a year ago, with earnings per share missing expectations and adjusted EBITDA down.

Sponsored

Management guided for an adjusted EBITDA loss of as much as $28 million in the fourth quarter, assuming no benefit from corrective actions already underway. CEO John Kao said the company is taking a prudent approach and is confident it can deliver against those reduced expectations, leaving little room for a positive surprise.

Health plan enrollment rose 31.2% year-over-year, and full-year revenue guidance was raised while full-year adjusted EBITDA guidance was lowered. Investors have to weigh member growth against deteriorating medical cost ratios.

Sources

Mentioned: ALHC